You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Patent: 10,398,685


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,398,685
Title:Methods of treating pancreatic cancer
Abstract: The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or regulating signaling proteins in patients comprising administering compounds and pharmaceutical combinations as described herein.
Inventor(s): Bekker; Petrus (Mountain View, CA), Miao; Shichang (Foster City, CA), Charo; Israel (Mountain View, CA), Schall; Tom (Mountain View, CA)
Assignee: ChemoCentryx, Inc. (Mountain View, CA)
Application Number:16/266,961
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 10,398,685

Introduction

United States Patent 10,398,685, like any other patent, is a complex document that grants exclusive rights to its inventor for a specific invention. To conduct a comprehensive and critical analysis of this patent, we need to delve into several key aspects, including the patent's claims, the broader patent landscape, and the legal and strategic implications.

Understanding the Patent Claims

Claim Structure and Scope

The claims of a patent are its most critical component, as they define the scope of the invention and the rights granted to the inventor. For US Patent 10,398,685, it is essential to analyze each claim to understand what is being protected. This includes identifying the independent and dependent claims, as well as any limitations or specific embodiments described in the claims[3].

Novelty and Non-Obviousness

To ensure the validity of the patent, the claims must meet the criteria of novelty and non-obviousness under 35 U.S.C. § 102 and § 103, respectively. This involves checking if the claimed invention is anticipated by prior art or if it represents an obvious combination of existing technologies. The analysis must consider whether each element of the claim is found in a single prior art reference or if the claimed subject matter is disclosed with sufficient specificity[3].

Prior Art Search and Analysis

Importance of Prior Art

Conducting a thorough prior art search is crucial to determine the novelty and non-obviousness of the invention. This search involves reviewing existing patents, publications, and other relevant documents to identify any disclosures that may anticipate the claimed invention. For US Patent 10,398,685, a detailed prior art search would help in assessing whether the invention is truly novel and non-obvious[2][3].

Case Law and Precedents

The analysis should also consider relevant case law and precedents that have shaped the interpretation of novelty and non-obviousness. For example, cases like Verdegaal Bros. v. Union Oil Co. of California and UCB, Inc. v. Actavis Labs. UT, Inc. provide guidance on what constitutes anticipation and the specificity required in prior art disclosures[3].

Patent Landscape Analysis

Technology Classification

To understand the position of US Patent 10,398,685 within the broader patent landscape, it is necessary to classify the technology area in which it falls. This can be done using the USPTO's technology classification scheme or other relevant classification systems. Identifying the technology field helps in comparing the patent with other patents in the same area and assessing its uniqueness and impact[1][2].

Competitive Intelligence

Analyzing the patent landscape involves identifying competitors and key players in the technology field. This includes reviewing their patent portfolios to assess their strengths and weaknesses. For US Patent 10,398,685, understanding the competitive landscape can help in developing strategies to protect and expand market share[2].

Freedom to Operate (FTO) Analysis

FTO analysis is essential to ensure that the product or process described in the patent does not infringe on existing patents. This analysis helps businesses avoid legal disputes and costly patent infringement litigation by ensuring they have the right to manufacture, use, or sell their products without violating someone else's intellectual property rights[2].

Legal and Regulatory Compliance

Post-Grant Proceedings

The Patent Trial and Appeal Board (PTAB) plays a significant role in post-grant proceedings, such as Inter Partes Review (IPR), which can challenge the validity of granted patents. Understanding the procedures and recent developments in PTAB, as well as any proposed reforms, is crucial for maintaining the validity of US Patent 10,398,685[4].

Subject Matter Eligibility

The patent must comply with subject matter eligibility guidelines as outlined by the USPTO. This involves determining whether the patent claims are directed to ineligible subject matter, such as laws of nature, natural phenomena, or abstract ideas, and whether they contain an inventive concept that transforms the nature of the ineligible concept[4].

Strategic Implications

R&D Strategy

Analyzing the patent can help refine R&D strategies by identifying white spaces or areas with fewer patents, indicating potential opportunities for innovation. This analysis can also inform decisions on where to invest in new technologies, form partnerships, or license existing patents[2].

Valuation of Intellectual Property

The patent's value can be assessed through patent analysis, which is essential for licensing, mergers and acquisitions, and negotiations with potential investors or partners. This involves evaluating the potential economic value of the patent, considering factors such as market size, licensing opportunities, and litigation risks[2].

Market Assessment

Patent analysis provides insights into the size and dynamics of the market, helping businesses understand the competitive landscape and barriers to entry. This information is vital for making informed decisions about entering new markets or expanding existing ones[2].

Innovation Insights and Trends

Emerging Trends

By studying patent data, businesses can gain insights into emerging trends and technological advancements in their industry. This helps in staying competitive and making informed R&D decisions. For US Patent 10,398,685, identifying trends can highlight its position within the evolving technology landscape[2].

Citation Analysis

Analyzing patent citations can help understand how the patent relates to prior and subsequent innovations. This type of analysis can gauge the importance of the patent within its technological field and identify potential areas for further innovation[2].

Risk Mitigation

Identifying Vulnerabilities

Conducting a thorough patent analysis helps identify potential risks associated with the intellectual property strategy. This includes identifying patents that may be vulnerable to challenges and assessing the validity and enforceability of the patents[2].

Litigation Risks

Understanding the litigation risks associated with the patent is crucial. This involves assessing the likelihood of patent infringement disputes and the potential outcomes of such disputes. For US Patent 10,398,685, mitigating these risks can protect the inventor's rights and business interests[2].

Key Takeaways

  • Claims Analysis: The claims of US Patent 10,398,685 must be meticulously analyzed to understand the scope of protection and ensure compliance with novelty and non-obviousness requirements.
  • Prior Art Search: A thorough prior art search is essential to validate the patent's novelty and non-obviousness.
  • Patent Landscape: Understanding the technology classification, competitive landscape, and FTO analysis helps in strategic decision-making.
  • Legal Compliance: Ensuring compliance with subject matter eligibility guidelines and being aware of post-grant proceedings is vital.
  • Strategic Implications: The patent's analysis informs R&D strategies, intellectual property valuation, market assessment, and risk mitigation.

FAQs

What is the significance of prior art in patent analysis?

Prior art is crucial in determining the novelty and non-obviousness of a patent. It involves reviewing existing patents, publications, and other relevant documents to ensure that the claimed invention is not anticipated by earlier disclosures[3].

How does the Patent Trial and Appeal Board (PTAB) impact patent validity?

PTAB is a tribunal within the USPTO that hears administrative challenges to the validity of granted patents. It plays a significant role in post-grant proceedings such as IPR, which can challenge the validity of patents and affect their enforceability[4].

What is the importance of Freedom to Operate (FTO) analysis?

FTO analysis ensures that a product or process does not infringe on existing patents, helping businesses avoid legal disputes and costly patent infringement litigation. It is essential for ensuring the right to manufacture, use, or sell products without violating someone else's intellectual property rights[2].

How can patent analysis inform R&D strategies?

Patent analysis helps identify white spaces or areas with fewer patents, indicating potential opportunities for innovation. It also informs decisions on where to invest in new technologies, form partnerships, or license existing patents[2].

What role does citation analysis play in patent evaluation?

Citation analysis helps understand how a patent relates to prior and subsequent innovations. It gauges the importance of the patent within its technological field and identifies potential areas for further innovation[2].

Sources Cited

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Evalueserve. Patent Analysis.
  3. USPTO. 2131-Anticipation — Application of 35 U.S.C. 102.
  4. Congressional Research Service. The Patent Trial and Appeal Board and Inter Partes Review.

More… ↓

⤷  Try for Free

Details for Patent 10,398,685

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 May 05, 2004 ⤷  Try for Free 2036-06-13
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 December 02, 2004 ⤷  Try for Free 2036-06-13
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 October 26, 2004 ⤷  Try for Free 2036-06-13
Akorn, Inc. HYDASE hyaluronidase Injection 021716 October 25, 2005 ⤷  Try for Free 2036-06-13
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 January 10, 1978 ⤷  Try for Free 2036-06-13
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.